Hematology & Clinical Pathology
The Department of Haematology and Clinical Pathology is a dynamic, integrated centre that blends patient care, advanced diagnostics, and clinical research. Designed with an innovative, technology-driven layout, the department showcases its capabilities through modern workstations and transparent workflows that highlight precision and efficiency in laboratory operations. It unites state-of-the-art laboratory haematology with specialised consultative expertise to support both diagnostic and clinical decision-making. The NABL-accredited laboratory features cutting-edge automated systems for comprehensive haematological testing and offers expert diagnostic interpretation for a wide range of blood-related diseases and disorders.
 |
Services Rendered by the department: From January'25 to December'25
| INVESTIGATIONS | 2024 | 2025 |
|---|---|---|
| Haematology routine | ||
| Absolute counts | 587 | 693 |
| Complete blood counts | 92044 | 108398 |
| Complete Hemogram | 10978 | 17221 |
| ESR | 1646 | 1639 |
| Hb/PCV+RBC/MCHC/MCV | 3325 | 5194 |
| Malaria Parasite (MP)/Microfilaria | 313 | 296 |
| Malaria Antigen Detection Test | 350 | 335 |
| Platelet count | 222 | 1189 |
| TLC and DLC | 1175 | 802 |
| Peripheral Smear Examination | 2020 | 2634 |
| Haemolytic workup | ||
| G6PD deficiency test | 590 | 807 |
| Reticulocyte Count | 2180 | 2508 |
| Bone marrow evaluation | ||
| Bone marrow aspiration procedure and reporting | 226 | 221 |
| Bone marrow biopsy procedure and reporting | 234 | 228 |
| Issue of Bone marrow slides | 25 | 33 |
| Iron stain | 226 | 221 |
| Coagulation lab services | ||
| Prothrombin time | 72218 | 88508 |
| Activated partial thromboplastin time | 5377 | 7078 |
| Vw-Von Willebrand Antigen | 942 | 658 |
| Adam TS -13 | 861 | 416 |
| Fibrinogen assay | 7535 | 8015 |
| Protein C | 160 | 191 |
| Protein S | 160 | 185 |
| EXTEM | 5522 | 5379 |
| FIBTEM | 5513 | 5364 |
| APTEM | 51 | 24 |
| Heptem | 173 | 82 |
| Intem | 546 | 320 |
| Antithrombin III | 151 | 163 |
| Fibrin degradation products | 268 | 228 |
| D-dimer | 761 | 1044 |
| Factor VIII assay | 226 | 258 |
| Bleeding time | 9 | 15 |
| Clotting time | 9 | 15 |
| Mixing studies | 2 | 05 |
| Platelet aggregation test (PAT) | - | 368 |
| Clinical pathology | ||
| Urine routine and microscopy | 20392 | 27210 |
| Urine for reducing substance | 72 | 28 |
| Urine for Dysmorphic RBC Test | 163 | 223 |
| Urine for ketones | 265 | 269 |
| Urine for Bence Jones protein | 9 | 17 |
| Body Fluid for TLC | 7885 | 9762 |
| Body Fluid for DLC | 7885 | 9762 |
| Urine sugar/Urobilinogen/urine protein | 07 | 31 |
New services & facilities added to the department in 2025:
- 1. Platelet aggregation test (epinephrine, ADP, collagen and ristocetin).
- 2. VWF Activity
- 3. VWF antigen
- 4. ADAMTS13
 |
Platelet Aggregation Test Principle: Platelet aggregation testing evaluates platelet adhesion, activation, granule release, and aggregation in response to various agonists.
Clinical Use: This test aids in diagnosing inherited and acquired platelet disorders. Initially developed to identify bleeding disorders, platelet function testing now also monitors the efficacy of antiplatelet therapy and assesses thrombosis risk. Platelets play roles beyond hemostasis and thrombosis, contributing to intercellular communication, inflammation, and immune modulation.
 |
The gold standard for platelet function testing is Light Transmission Aggregometry (LTA). This technique measures changes in light transmission through platelet-rich plasma as platelets aggregate. Initially, the plasma is cloudy, obstructing light. Upon stimulation with agonists like epinephrine, ADP, or collagen, platelet aggregation clears the sample, increasing light transmission, which is recorded over time.
LTA results help identify specific platelet function abnormalities. Inherited and acquired platelet disorders exhibit characteristic patterns, indicating whether responses to agonists are normal, reduced, or absent. However, mild or moderate abnormalities may lack distinct patterns, complicating diagnosis.
Emerging biomarkers and technologies expand the scope of platelet testing, highlighting its importance in both bleeding and thrombotic disorders, as well as its role in broader biological processes like inflammation and immunity.
Educational Activities
- a. Courses offered by the Department
- i) Short-Term Training in Haematology
- ii) Technician training course
Departmental Achievements
- The Department of Hematology and Clinical Pathology consistently delivers high-quality diagnostic services, fully aligned with NABL and NABH accreditation standards.
- The department actively supports multiple research initiatives by offering essential laboratory expertise and services.
- Introduction of several new assays and diagnostic parameters in the coagulation laboratory has expanded the department's testing capabilities.
- Academic contributions from the department have been selected for presentation at esteemed international conferences.
